Tagged with Top

Pharma Below is a list of the Top 100 Pharma Companies in Turkey sorted by the total value of sales in USD for 2014. Global giant Novartis is number one in a market worth a total of more than seven billion dollars. Source: IMS Health Click here to read more articles and…

Turkey The following is a list of the Top 100 Pharma Companies in Turkey sorted by total value of sales in USD for 2014. Global giant Novartis is number one in a market worth a total of more than seven billion dollars. Source: IMS Health Click here to read more articles and…

Pharma Christophe Lala, general manager of Western Europe at GE Healthcare, reveals how today the challenge is to ensure that all patients in France have access to the same medical pathway; how the future of medicine lies in early diagnosis and individually tailored treatments, what is known as personalized medicine; and…

France The recently appointed general manager of Galderma France, reveals the company’s ambitious objective for the next ten years: to increase sales from two to ten billion Euros (2.18 billion USD to 10.9 billion USD). Mr Mosse talks about their strategy to expand beyond the traditional dermatology prescription market and explore opportunities…

Puerto Rico Click here to read more articles and interviews from Puerto Rico, and to download the latest free pharma report on the country. 

Pharma Gerard van Harten highlights the key role of the chemical industry in bringing innovation to the pharmaceutical and biotech sectors. He discusses how Top Sector Chemistry has developed the Chemistry of Life roadmap and is promoting inter-sectoral chemical-pharmaceutical collaboration in order to foster innovation that will impact healthcare around the…

biotech Local flagship company Boryung has found success with its newly developed angiotension receptor blocker (ARB) Kanarb. Nine molecules currently exist worldwide in this category of antihypertensives, and Kanarb is currently ranked eighth. “Boryung is the only domestic company that has developed a drug from start to finish, including outlicensing. Of…

Apitope Apitope’s research and success is based on its High Speed Technology Platform that uses soluble peptides as vehicles to regulate immune responses in patients. What is the history behind this technology and how does it differ from other peptide-based research? Apitope was founded on a platform technology to discover peptides…

OctoPlus N.V. Clearly the end of 2010 was an exciting time for you. As you entered the transition period as the new CEO of OctoPlus, you also participated in the equity raising. In your view, what makes OctoPlus stand out in the market? There are two main components, one being the people…

Top Institute Pharma There is a very interesting history behind the origins of Top Institute Pharma (TI Pharma) as it aligned the interests of both the World Health Organization (Priority Medicines) and the EU’s Lisbon Strategy. Lisbon’s goal in 2000 was to transform the EU into the most powerful knowledge economy by 2010…